We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Altimmune Inc | NASDAQ:ALT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.46 | 7.02% | 7.01 | 7.05 | 7.11 | 7.39 | 6.55 | 6.64 | 4,119,410 | 00:59:52 |
Details on the Jefferies fireside chat presentation are as follows:
Title: | 2021 Jefferies Virtual Healthcare Conference | ||
Presenters: | Vipin Garg, Ph.D., Chief Executive Officer | ||
Scot Roberts, Ph.D., Chief Scientific Officer | |||
Scott Harris, M.D., Chief Medical Officer | |||
Date/Time: | Wednesday, June 2, 2021 at 11:30 am ET |
A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.
Investor & Media Contacts: | ||
Will Brown | Stacey Jurchison | |
Chief Financial Officer | Sr. Dir, Investor Relations | |
Phone: 240-654-1450 | Phone : 410-474-8200 | |
wbrown@altimmune.com | sjurchison@altimmune.com |
1 Year Altimmune Chart |
1 Month Altimmune Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions